应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
SNDX Syndax Pharmaceuticals, Inc.
休市中 05-03 16:00:00 EDT
22.05
+0.19
+0.87%
盘后
20.95
-1.10
-4.99%
17:29 EDT
最高
22.66
最低
21.90
成交量
70.47万
今开
22.39
昨收
21.86
日振幅
3.48%
总市值
18.74亿
流通市值
18.66亿
总股本
8,498万
成交额
1,563万
换手率
0.83%
流通股本
8,464万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Syndax Pharmaceuticals, Inc.盘中异动 大幅跳水5.09%
自选股智能写手 · 04-11
Syndax Pharmaceuticals, Inc.盘中异动 大幅跳水5.09%
美国研究综述-迪克体育用品、Nvidia、PVH
Reuters · 03-20
美国研究综述-迪克体育用品、Nvidia、PVH
Syndax Pharmaceuticals Inc盘中异动 早盘股价大跌5.09%
自选股智能写手 · 01-24
Syndax Pharmaceuticals Inc盘中异动 早盘股价大跌5.09%
Syndax Pharmaceuticals Inc盘中异动 下午盘快速下挫5.22%报20.72美元
自选股智能写手 · 01-04
Syndax Pharmaceuticals Inc盘中异动 下午盘快速下挫5.22%报20.72美元
Syndax Pharmaceuticals Inc盘中异动 股价大涨5.04%报18.56美元
自选股智能写手 · 2023-12-14
Syndax Pharmaceuticals Inc盘中异动 股价大涨5.04%报18.56美元
暂无数据
公司概况
公司名称:
Syndax Pharmaceuticals, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Syndax Pharmaceuticals, Inc.于2005年10月11日根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司,正在开发癌症疗法的创新管道。该公司正在开发revumenib,这是一种有效的、选择性的、menin-MLL结合相互作用的小分子抑制剂,用于治疗KMT2A重排或KMT2AR,也称为混合谱系白血病重排或MLLR,包括急性淋巴细胞白血病或ALL在内的急性白血病,以及急性髓细胞白血病或AML,以及necleophosmin 1,也称为NPM1,突变AML。
发行价格:
--
{"stockData":{"symbol":"SNDX","market":"US","secType":"STK","nameCN":"Syndax Pharmaceuticals, Inc. ","latestPrice":22.05,"timestamp":1714766400000,"preClose":21.86,"halted":0,"volume":704685,"hourTrading":{"tag":"盘后","latestPrice":20.95,"preClose":22.05,"latestTime":"17:29 EDT","volume":120692,"amount":2661047.97,"timestamp":1714771797185},"delay":0,"floatShares":84639673,"shares":84979686,"eps":-2.98,"marketStatus":"休市中","marketStatusCode":7,"change":0.19,"latestTime":"05-03 16:00:00 EDT","open":22.39,"high":22.66,"low":21.9,"amount":15626656.950615,"amplitude":0.034767,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.98,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1714982400000},"adr":0,"listingDate":1456981200000,"adjPreClose":21.86,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":20.95,"preClose":22.05,"latestTime":"17:29 EDT","volume":120692,"amount":2661047.97,"timestamp":1714771797185},"volumeRatio":0.6065714597946277},"requestUrl":"/m/hq/s/SNDX/tweets","defaultTab":"tweets","newsList":[{"id":"2426410129","title":"Syndax Pharmaceuticals, Inc.盘中异动 大幅跳水5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426410129","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426410129?lang=zh_cn&edition=full","pubTime":"2024-04-11 00:30","pubTimestamp":1712766644,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日00时30分,Syndax Pharmaceuticals, Inc.股票出现异动,股价大幅跳水5.09%。Syndax Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.25%。其相关个股中,Adial Pharmaceuticals, Inc、Jaguar Health, Inc.、Orgenesis Inc.涨幅较大,Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Jaguar Health, Inc.较为活跃,换手率分别为1915.38%、76.53%、51.56%,振幅较大的相关个股有Adial Pharmaceuticals, Inc、Orgenesis Inc.、Nutriband Inc C/Wts ,振幅分别为87.61%、74.23%、52.44%。Syndax Pharmaceuticals, Inc.公司简介:Syndax Pharmaceuticals Inc是一家临床阶段的生物制药公司,致力于开发多种癌症适应症的联合疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404110030447a51ed0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404110030447a51ed0b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420798966","title":"美国研究综述-迪克体育用品、Nvidia、PVH","url":"https://stock-news.laohu8.com/highlight/detail?id=2420798966","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2420798966?lang=zh_cn&edition=full","pubTime":"2024-03-20 15:14","pubTimestamp":1710918896,"startTime":"0","endTime":"0","summary":" 路透社3月20日 - 华尔街证券分析师周三调整了对迪克体育用品公司、英伟达和 PVH 等几家美国上市公司的评级和目标价。股票条目按字母顺序排列。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2406440417","title":"Syndax Pharmaceuticals Inc盘中异动 早盘股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2406440417","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2406440417?lang=zh_cn&edition=full","pubTime":"2024-01-24 23:31","pubTimestamp":1706110279,"startTime":"0","endTime":"0","summary":"北京时间2024年01月24日23时31分,Syndax Pharmaceuticals Inc股票出现异动,股价大幅跳水5.09%。截至发稿,该股报20.15美元/股,成交量47.4493万股,换手率0.56%,振幅5.09%。Syndax Pharmaceuticals Inc股票所在的生物技术行业中,整体跌幅为0.67%。Syndax Pharmaceuticals Inc公司简介:Syndax Pharmaceuticals Inc是一家临床阶段的生物制药公司,致力于开发多种癌症适应症的联合疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240124233119790bcf94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240124233119790bcf94&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2400180318","title":"Syndax Pharmaceuticals Inc盘中异动 下午盘快速下挫5.22%报20.72美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2400180318","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2400180318?lang=zh_cn&edition=full","pubTime":"2024-01-04 04:24","pubTimestamp":1704313457,"startTime":"0","endTime":"0","summary":"北京时间2024年01月04日04时24分,Syndax Pharmaceuticals Inc股票出现波动,股价急速下挫5.22%。截至发稿,该股报20.72美元/股,成交量35.3万股,换手率0.42%,振幅5.08%。Syndax Pharmaceuticals Inc股票所在的生物技术行业中,整体涨幅为0.33%。Syndax Pharmaceuticals Inc公司简介:Syndax Pharmaceuticals Inc是一家临床阶段的生物制药公司,致力于开发多种癌症适应症的联合疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401040424187a382c44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202401040424187a382c44&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2391594480","title":"Syndax Pharmaceuticals Inc盘中异动 股价大涨5.04%报18.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2391594480","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2391594480?lang=zh_cn&edition=full","pubTime":"2023-12-14 04:30","pubTimestamp":1702499449,"startTime":"0","endTime":"0","summary":"北京时间2023年12月14日04时30分,Syndax Pharmaceuticals Inc股票出现波动,股价快速拉升5.04%。截至发稿,该股报18.56美元/股,成交量95.6231万股,换手率1.37%,振幅6.28%。Syndax Pharmaceuticals Inc股票所在的生物技术行业中,整体涨幅为3.45%。Syndax Pharmaceuticals Inc公司简介:Syndax Pharmaceuticals Inc是一家临床阶段的生物制药公司,致力于开发多种癌症适应症的联合疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312140430507a338be4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202312140430507a338be4&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.syndax.com","stockEarnings":[{"period":"1week","weight":0.047},{"period":"1month","weight":-0.0731},{"period":"3month","weight":0.0709},{"period":"6month","weight":0.4899},{"period":"1year","weight":0.0981},{"period":"ytd","weight":0.0204}],"compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0156},{"period":"3month","weight":0.0343},{"period":"6month","weight":0.1762},{"period":"1year","weight":0.262},{"period":"ytd","weight":0.0757}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Syndax Pharmaceuticals, Inc.于2005年10月11日根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司,正在开发癌症疗法的创新管道。该公司正在开发revumenib,这是一种有效的、选择性的、menin-MLL结合相互作用的小分子抑制剂,用于治疗KMT2A重排或KMT2AR,也称为混合谱系白血病重排或MLLR,包括急性淋巴细胞白血病或ALL在内的急性白血病,以及急性髓细胞白血病或AML,以及necleophosmin 1,也称为NPM1,突变AML。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.044305},{"month":2,"riseRate":0.625,"avgChangeRate":0.07889},{"month":3,"riseRate":0.625,"avgChangeRate":0.084467},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.000613},{"month":5,"riseRate":0.555556,"avgChangeRate":0.021305},{"month":6,"riseRate":0.5,"avgChangeRate":0.001339},{"month":7,"riseRate":0.5,"avgChangeRate":-0.000294},{"month":8,"riseRate":0.625,"avgChangeRate":0.063716},{"month":9,"riseRate":0.625,"avgChangeRate":-0.024123},{"month":10,"riseRate":0.25,"avgChangeRate":-0.081003},{"month":11,"riseRate":0.625,"avgChangeRate":0.015744},{"month":12,"riseRate":0.5,"avgChangeRate":0.063584}],"exchange":"NASDAQ","name":"Syndax Pharmaceuticals, Inc. ","nameEN":"Syndax Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Syndax Pharmaceuticals, Inc. (SNDX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Syndax Pharmaceuticals, Inc. (SNDX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Syndax Pharmaceuticals, Inc. ,SNDX,Syndax Pharmaceuticals, Inc. 股票,Syndax Pharmaceuticals, Inc. 股票老虎,Syndax Pharmaceuticals, Inc. 股票老虎国际,Syndax Pharmaceuticals, Inc. 行情,Syndax Pharmaceuticals, Inc. 股票行情,Syndax Pharmaceuticals, Inc. 股价,Syndax Pharmaceuticals, Inc. 股市,Syndax Pharmaceuticals, Inc. 股票价格,Syndax Pharmaceuticals, Inc. 股票交易,Syndax Pharmaceuticals, Inc. 股票购买,Syndax Pharmaceuticals, Inc. 股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Syndax Pharmaceuticals, Inc. (SNDX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Syndax Pharmaceuticals, Inc. (SNDX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}